Clinical trial
An Advanced Echocardiographic Evaluation of Nebivolol
NCT01206439 is registered in ClinicalTrials.gov with Jack Rubinstein as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Advanced Echocardiographic Evaluation of Nebivolol
- Lead sponsor
- Jack Rubinstein
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- September 30, 2010
- Completion date
- August 31, 2012
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.